에 대한 최신 뉴스 MAC Copper (NYSE:MTAL) 주식

MAC Copper Ltd is a company focused on operating and acquiring metals and mining businesses in high-quality, stable jurisdictions that are critical in the electrification and decarbonization of the world-wide economy.

Commodities

FEAM

GROY

MTAL

2024년 5월 28일 주요 뉴스 골드 로열티(NYSE:GROY): 밴쿠버에 본사를 둔 이 회사는 오리온 마인 파이낸스(Orion Mine Finance)로부터 바레스 실버 프로젝트(Vares Silver Project)의 구리 스트림을 5천만 달러에 구매하기로 합의했다. 지급액에는 현금 4,500만 달러와 500만 달러 상당의 골드 로열티 주식이 포함된다.

화요일 주요 광업 뉴스: 골드 로열티, BHP와 리오 틴토, 메탈스 에퀴지션 등

2024년 5월 21일 주요 뉴스: 1. U.S. 스틸(NYSE:X)의 이사회는 올해 하반기에 종료될 것으로 예상되는 일본제철(Nippon Steel)과의 전액 현금 거래에 대한 잘못된 정보를 다루었다.

화요일 주요 광업 뉴스: U.S. 스틸, 파라마운트 골드 네바다, 메탈스 에퀴지션, 알코아

Earnings

LMSQF

알파 메탈러지컬(NYSE:AMR)은 2024년 1분기 순이익은 1억 2,700만 달러, 즉 희석 주당 9.59달러, 조정 EBITDA는 1억 8,960만 달러, 매출은 8억 6,400만 달러를 기록했다.최고경영자(CEO) 앤디 아이드슨(Andy Eidson)은 석탄 시장의 약세 조건에도 불구하고 강력한 실적을 이끌어냈다고 언급했으며, 이에 따라 이번 분기 이후로도 시장 악화 조짐이 계속되고 있다고 덧붙였다. 

월요일 주요 광업 뉴스: 알파 메탈러지컬, 메탈스 에퀴지션, 라틴 메탈스, 아이다호 스트래티직

MAC Copper Ltd

Metallica Metals Corp

Quebec Rare Earth Elements Corp

Benzinga's options scanner just detected over 9 options trades for NextDecade (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXT#NASDAQ">NEXT</a>) summing a total amount of $1,381,889.
At the same time, our algo caught 2 for a total amount of 71,571.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $4.0 to $8.0 for NextDecade during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for NextDecade's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of NextDecade's whale trades within a strike price range from $4.0 to $8.0 in the last 30 days. 
<h3>NextDecade Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737056003_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NEXT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$3.6</td>
<td>$3.5</td>
<td>$3.6</td>
<td>$5.00</td>
<td>$713.4K</td>
<td>26.3K</td>
<td>2.6K</td>
</tr>
<tr>
<td>NEXT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.65</td>
<td>$1.6</td>
<td>$1.65</td>
<td>$7.00</td>
<td>$251.1K</td>
<td>7.3K</td>
<td>1.5K</td>
</tr>
<tr>
<td>NEXT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$3.6</td>
<td>$3.5</td>
<td>$3.6</td>
<td>$5.00</td>
<td>$214.6K</td>
<td>26.3K</td>
<td>614</td>
</tr>
<tr>
<td>NEXT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$4.6</td>
<td>$4.3</td>
<td>$4.3</td>
<td>$4.00</td>
<td>$86.0K</td>
<td>249</td>
<td>200</td>
</tr>
<tr>
<td>NEXT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.7</td>
<td>$1.55</td>
<td>$1.65</td>
<td>$7.00</td>
<td>$50.6K</td>
<td>7.3K</td>
<td>1.9K</td>
</tr>
</tbody>
</table>

<h3>About NextDecade</h3>
NextDecade Corp is a energy company predominantly engaged in construction and development activities related to the liquefaction of natural gas and sale of LNG and the capture and storage of CO2 emissions. The company provides a number of services depending on the individual needs of the customer. These include the supply and trade of LNG volumes, the creation of new natural gas infrastructure including pipeline and natural gas liquefaction facilities, treatment and processing of natural gas into LNG, as well as technical engineering and design services related to the development and execution of natural gas infrastructure, transporting, shipping and storage of LNG.
Following our analysis of the options activities associated with NextDecade, we pivot to a closer look at the company's own performance.
<h3>Where Is NextDecade Standing Right Now?</h3>
<ul>
<li>With a volume of 4,321,781, the price of NEXT is down -1.73% at $7.96. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 53 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for NextDecade with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Markets

Behind the Scenes of NextDecade's Latest Options Trends

Investors with a lot of money to spend have taken a bullish stance on EOG Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EOG#NYSE">EOG</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with EOG, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 8 options trades for EOG Resources.
This isn't normal.
The overall sentiment of these big-money traders is split between 50% bullish and 37%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $35,000, and 7, calls, for a total amount of $489,627.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $120.0 to $150.0 for EOG Resources over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of EOG Resources stands at 541.83, with a total volume reaching 1,571.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in EOG Resources, situated within the strike price corridor from $120.0 to $150.0, throughout the last 30 days.
<h3>EOG Resources Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737055998_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>EOG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/31/25</td>
<td>$16.4</td>
<td>$16.4</td>
<td>$16.4</td>
<td>$121.00</td>
<td>$145.9K</td>
<td>115</td>
<td align="right">27</td>
</tr>
<tr>
<td>EOG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$13.9</td>
<td>$12.6</td>
<td>$12.81</td>
<td>$124.50</td>
<td>$73.9K</td>
<td>395</td>
<td align="right">55</td>
</tr>
<tr>
<td>EOG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/28/25</td>
<td>$4.8</td>
<td>$4.3</td>
<td>$4.4</td>
<td>$137.00</td>
<td>$70.8K</td>
<td>15</td>
<td align="right">161</td>
</tr>
<tr>
<td>EOG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/31/25</td>
<td>$15.4</td>
<td>$15.4</td>
<td>$15.4</td>
<td>$122.00</td>
<td>$70.8K</td>
<td>62</td>
<td align="right">46</td>
</tr>
<tr>
<td>EOG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$10.0</td>
<td>$9.3</td>
<td>$9.3</td>
<td>$150.00</td>
<td>$57.7K</td>
<td>2.2K</td>
<td align="right">68</td>
</tr>
</tbody>
</table>

<h3>About EOG Resources</h3>
EOG Resources is an oil and gas producer with acreage in several US shale plays, primarily in the Permian Basin and the Eagle Ford. At the end of 2023, it reported net proven reserves of 4.5 billion barrels of oil equivalent. Net production averaged roughly 985,000 barrels of oil equivalent per day in 2023 at a ratio of 71% oil and natural gas liquids and 29% natural gas.
Following our analysis of the options activities associated with EOG Resources, we pivot to a closer look at the company's own performance.
<h3>EOG Resources's Current Market Status</h3>
<ul>
<li>With a volume of 1,265,323, the price of EOG is up 0.27% at $137.43. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 35 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for EOG Resources with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

EOG Resources Unusual Options Activity For January 16

Deep-pocketed investors have adopted a bullish approach towards Enphase Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ENPH usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 17 extraordinary options activities for Enphase Energy. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 52% leaning bullish and 47% bearish. Among these notable options, 11 are puts, totaling $1,117,668, and 6 are calls, amounting to $297,956.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $50.0 and $75.0 for Enphase Energy, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Enphase Energy's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Enphase Energy's whale trades within a strike price range from $50.0 to $75.0 in the last 30 days. 
<h3>Enphase Energy Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737055992_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ENPH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$2.55</td>
<td>$2.16</td>
<td>$2.3</td>
<td>$65.00</td>
<td>$183.9K</td>
<td>5.4K</td>
<td>833</td>
</tr>
<tr>
<td>ENPH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$12.7</td>
<td>$12.45</td>
<td>$12.46</td>
<td>$75.00</td>
<td>$179.7K</td>
<td>6.7K</td>
<td>612</td>
</tr>
<tr>
<td>ENPH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$12.5</td>
<td>$12.25</td>
<td>$12.5</td>
<td>$75.00</td>
<td>$177.5K</td>
<td>6.7K</td>
<td>276</td>
</tr>
<tr>
<td>ENPH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$12.8</td>
<td>$12.45</td>
<td>$12.53</td>
<td>$75.00</td>
<td>$153.0K</td>
<td>6.7K</td>
<td>468</td>
</tr>
<tr>
<td>ENPH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$12.8</td>
<td>$12.55</td>
<td>$12.8</td>
<td>$75.00</td>
<td>$131.8K</td>
<td>6.7K</td>
<td>1.1K</td>
</tr>
</tbody>
</table>

<h3>About Enphase Energy</h3>
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
In light of the recent options history for Enphase Energy, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Enphase Energy's Current Market Status</h3>
<ul>
<li>With a trading volume of 2,772,157, the price of ENPH is down by -3.24%, reaching $63.7.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 19 days from now.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Enphase Energy, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

ENPH

Looking At Enphase Energy's Recent Unusual Options Activity

Oil and gas giant BP Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>) is reducing its workforce by 4,700 positions, which accounts for 5% of its employees, and eliminating more than 3,000 contractor jobs.
The oil giant aims to streamline its operations and reduce costs as part of an ongoing initiative to cut <a href="https://www.benzinga.com/news/earnings/24/05/38665532/why-bp-shares-are-trading-lower-premarket-today">$2 billion by the end of 2026.</a>
CEO Murray Auchincloss communicated these cuts to staff as part of the company&#8217;s ongoing cost-reduction efforts.
Since June 2024, BP suspended or paused 30 projects to concentrate on its most lucrative initiatives, according to a report from <a href="https://www.bloomberg.com/news/articles/2025-01-16/bp-eliminates-thousands-of-jobs-in-cost-cutting-effort-ceo-says?srnd=phx-industries-energy&amp;sref=TBDibEcD">Bloomberg</a>.
BP employs approximately 90,000 people worldwide, and while the cuts will affect several regions, specific details on country-level job losses have not been disclosed, reported <a href="https://www.bbc.com/news/articles/ckgy3ve1q69o">BBC</a>.
The restructuring comes under the leadership of CEO Auchincloss, who <a href="https://www.bp.com/en/global/corporate/news-and-insights/press-releases/murray-auchincloss-appointed-bp-chief-executive-officer.html">took the helm a year ago</a>.
The CEO, in his memo to the employees, stated that the company's pivot toward more digital capabilities, including artificial intelligence in engineering and marketing, would boost its operations.
Also Read: <a href="https://www.benzinga.com/25/01/43027582/toyota-subsidiary-agrees-to-16b-settlement-over-emission-data-fraud">Toyota Subsidiary Agrees To $1.6B Settlement Over Emission Data Fraud</a>
BP's decision to scale back its oil and gas production reduction targets for 2030 has been controversial, with some of the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/01/36829332/battleground-for-oil-majors-bp-activist-investor-calls-for-cut-in-green-energy-pled">investors supporting the decision</a>.
In 2020, BP set a goal to <a href="https://www.bp.com/en/global/corporate/news-and-insights/press-releases/from-international-oil-company-to-integrated-energy-company-bp-sets-out-strategy-for-decade-of-delivery-towards-net-zero-ambition.html">reduce its oil and gas</a> production by 40% by 2030.&nbsp;The goal was <a href="https://www.bp.com/en/global/corporate/sustainability/getting-to-net-zero/five-aims-to-get-bp-to-net-zero.html">abandoned in October 2024</a>. 
Earlier this week, BP said production in its fiscal fourth quarter is expected to be <a href="https://www.benzinga.com/25/01/42971311/bp-warns-of-lower-oil-gas-output-in-fourth-quarter-update">lower than in the third quarter</a>. 
For the fourth quarter, the company anticipates a decline in upstream production compared to the previous quarter, with reductions in both oil and gas &amp; low-carbon energy output.
In the gas and low-carbon energy segment, realizations are expected to improve by $0.1 to $0.2 billion, driven by fluctuations in non-Henry Hub natural gas prices.
In the oil production and operations sector, BP predicts a negative impact on realizations of $0.2 billion to $0.4 billion, primarily due to price lags, especially in the Gulf of Mexico and UAE.
The company&#8217;s operating revenues for the third quarter came in at $47.254 billion, missing the <a href="https://www.benzinga.com/news/earnings/24/10/41598840/bp-stock-drops-as-q3-revenue-misses-mark-production-declines-debt-rises">consensus of $52.557 billion</a>.
Investors can gain exposure to the stock via Texas Capital Texas Oil Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OILT#NYSE">OILT</a>) and Amplify Natural Resources Dividend Income ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NDIV#NYSE">NDIV</a>).
BP Price Action: BP shares are trading higher by 1.55% at $31.79 at publication Thursday.
Read Next: <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43037588/stocks-pause-chipmakers-rise-gold-hits-2-month-highs-whats-driving-markets-thursday">• Stocks Pause, Chipmakers Rise, Gold Hits 2-Month Highs: What&#8217;s Driving Markets Thursday?</a>
Photo: Jon Lyall via Shutterstock

News

Global

General

NDIV

OILT

BP Slashes Workforce By 5% To Reach $2 Billion In Savings Goal

Atomera Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATOM#NASDAQ">ATOM</a>) shares are trading lower Thursday potentially continuing a momentum-driven decline as markets react to <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43001512/inflation-rises-to-29-in-december-core-slows-yet-rising-energy-costs-put-feds-target-at-risk">mixed inflation data for December</a>.
What To Know: The data showed consumer prices rising 2.9% year-over-year, marking the highest annual rate since July 2024. The Consumer Price Index (CPI) increase, driven largely by a 2.6% rise in the energy index, has renewed concerns over the Federal Reserve&#8217;s ability to achieve its 2% inflation target.
While core inflation, excluding food and energy, rose 3.2% annually—slightly below estimates—monthly core prices climbed 0.2%, in line with expectations.
Market sentiment reflected optimism in equity indices, with S&amp;P 500 futures up 1.5% and Nasdaq 100 contracts gaining 1.6%. However, Atomera shares diverged, likely impacted by broader concerns about rate-sensitive sectors and continued negative sentiment around the stock.
Treasury yields also fell following the inflation report, with the two-year yield dropping 9 basis points to 4.28% while the U.S. dollar weakened. Despite these broader market moves, Atomera's sharp decline may suggest company-specific pressures are compounding its struggles amid macroeconomic uncertainty.
ATOM Price Action: Atomera shares were down 20.2% at $8.91 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011625&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="547" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16140018/Screenshot-2025-01-16-at-13.59.43-1024x547.png" alt="" class="wp-image-737532" style="width:469px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16140018/Screenshot-2025-01-16-at-13.59.43-1024x547.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16140018/Screenshot-2025-01-16-at-13.59.43-300x160.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16140018/Screenshot-2025-01-16-at-13.59.43-768x410.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16140018/Screenshot-2025-01-16-at-13.59.43.png 1510w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/25/01/43038294/can-ai-solve-cannabis-medicines-data-problem-new-tech-initiative-aims-to-streamline-research-and-treatments">Can AI Solve Cannabis Medicine&#8217;s Data Problem? New Tech Initiative Aims To Streamline Research And Treatments</a></li>
</ul>
Image: Shutterstock/ Atomic62 Studio.

Movers

ATOM

Atomera Shares Plunge Amid Broader Market Movements: What's Going On?

On Wednesday, ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) released progress in its ongoing FDA discussions regarding three areas of its clinical development pipeline in non-muscle invasive bladder cancer (NMIBC) and non-small <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b43017050/immunitybio-provides-regulatory-update-on-anticipated-fda-submissions-in-2025-following-meeting-wi" rel="noreferrer noopener">cell lung cancer (NSCLC)</a>.
<ul>
<li>NMIBC BCG Unresponsive Papillary Disease: ImmunityBio is preparing to submit a supplemental Biologics License Application (sBLA) in 2025 for its treatment targeting Bacillus Calmette-Guérin (BCG) unresponsive NMIBC in the papillary indication. As published in the Chamie 2022 NEJM publication, the primary endpoint was met with a disease-free rate of 55% at 12 months, 51% at 18 months, and 48% at 24 months.</li>
<li>In addition, patients receiving Anktiva+BCG achieved a 93% avoidance of cystectomy with a median follow-up of 20.7 months.</li>
<li>Alternative Source of BCG: In collaboration with the Serum Institute of India, ImmunityBio plans a regulatory submission for an alternative source of BCG in the <a href="https://www.benzinga.com/general/biotech/24/05/38619196/serum-institute-of-india-inks-large-scale-supply-deal-for-bcg-use-in-immunitybios-bladder-cancer-" target="_blank" rel="noreferrer noopener">first quarter of 2025</a>. Serum Institute&#8217;s GMP capacity to manufacture large-scale volumes of BCG, already tested for safety and efficacy in clinical trials in Europe in subjects with NMIBC, aims to address the shortage of BCG.</li>
</ul>
Price Action: IBRX stock is up 18.6% at $2.835 at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/contracts/25/01/43026684/symbotic-soars-after-robotics-deal-with-walmart-whats-going-on" target="_blank" rel="noreferrer noopener">Symbotic Soars After Robotics Deal With Walmart &#8211; What&#8217;s Going On?</a></li>
</ul>
Photo via Shutterstock.

Biotech

Equities

Health Care

Trading Ideas

IBRX

ImmunityBio Stock Trading Higher On Updates From Bladder Cancer Trials: Details

Katapult Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KPLT#NASDAQ">KPLT</a>) shares are trading higher by 63% to $11.41 during Thursday&#8217;s session after the company reported <a href="https://www.benzinga.com/pressreleases/25/01/g43025830/katapult-provides-update-on-fourth-quarter-performance-gross-originations-grow-double-digits-year-">$75.2 million in gross originations</a> for the fourth quarter of 2024, up 11.3% year-over-year and surpassing its November forecast of 6-8% growth.
What To Know: Katapult says this marks the ninth consecutive quarter of annual growth and the second-highest gross originations in the company's history. 
This performance was fueled by a 50% year-over-year increase in lease applications, with significant contributions from both new (51%) and repeat customers (61.5% of originations). Additionally, the company says Katapult Pay saw a 52% surge in gross originations. 
CEO Orlando Zayas attributed the success to strong holiday engagement and the evolving Katapult ecosystem. Zayas expressed optimism for sustained growth in 2025, with final financial results to be announced in March.
Read Also: <a href="https://www.benzinga.com/news/management/25/01/43029622/whats-going-on-with-bigbear-ai-stock-thursday-2">What&#8217;s Going On With BigBear.AI Stock Thursday?</a>
<h2 class="wp-block-heading">How To Buy KPLT Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Katapult Holdings&#8217; case, it is in the Financials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, KPLT has a 52-week high of $23.54 and a 52-week low of $5.08.

KPLT

Why Katapult Holdings (KPLT) Shares Are Up 63% Today

Whales with a lot of money to spend have taken a noticeably bullish stance on Verona Pharma.
Looking at options history for Verona Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNA#NASDAQ">VRNA</a>) we detected 14 trades.
If we consider the specifics of each trade, it is accurate to state that 64% of the investors opened trades with bullish expectations and 28% with bearish.
From the overall spotted trades, 7 are puts, for a total amount of $319,653 and 7, calls, for a total amount of $262,865.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $45.0 to $60.0 for Verona Pharma during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Verona Pharma's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Verona Pharma's significant trades, within a strike price range of $45.0 to $60.0, over the past month.
<h3>Verona Pharma Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737054978_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>VRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$3.7</td>
<td>$3.7</td>
<td>$3.7</td>
<td>$55.00</td>
<td>$75.1K</td>
<td>0</td>
<td>1.0K</td>
</tr>
<tr>
<td>VRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$4.3</td>
<td>$4.2</td>
<td>$4.3</td>
<td>$55.00</td>
<td>$68.3K</td>
<td>0</td>
<td>715</td>
</tr>
<tr>
<td>VRNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$5.4</td>
<td>$5.1</td>
<td>$5.4</td>
<td>$45.00</td>
<td>$56.9K</td>
<td>2.3K</td>
<td>80</td>
</tr>
<tr>
<td>VRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$4.8</td>
<td>$4.8</td>
<td>$4.8</td>
<td>$55.00</td>
<td>$46.5K</td>
<td>0</td>
<td>420</td>
</tr>
<tr>
<td>VRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$6.1</td>
<td>$5.2</td>
<td>$5.1</td>
<td>$55.00</td>
<td>$41.8K</td>
<td>0</td>
<td>82</td>
</tr>
</tbody>
</table>

<h3>About Verona Pharma</h3>
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
Following our analysis of the options activities associated with Verona Pharma, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Verona Pharma</h3>
<ul>
<li>Currently trading with a volume of 1,114,755, the VRNA's price is up by 5.52%, now at $53.09. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 42 days.</li>
</ul>
<h3>Professional Analyst Ratings for Verona Pharma</h3>
A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $66.33333333333333.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Truist Securities downgraded its action to Buy with a price target of $57. 
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on Verona Pharma with a target price of $74. 
&#x2A; An analyst from Roth MKM downgraded its action to Buy with a price target of $68. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Verona Pharma options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

VRNA

Verona Pharma's Options Frenzy: What You Need to Know

Investors with a lot of money to spend have taken a bearish stance on Symbotic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with SYM, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 10 options trades for Symbotic.
This isn't normal.
The overall sentiment of these big-money traders is split between 40% bullish and 60%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $30,800, and 9, calls, for a total amount of $382,572.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $20.0 to $32.5 for Symbotic during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of Symbotic stands at 912.88, with a total volume reaching 2,364.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Symbotic, situated within the strike price corridor from $20.0 to $32.5, throughout the last 30 days.
<h3>Symbotic Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737054972_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SYM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.5</td>
<td>$1.65</td>
<td>$1.65</td>
<td>$32.50</td>
<td>$77.1K</td>
<td>1.4K</td>
<td align="right">652</td>
</tr>
<tr>
<td>SYM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$8.7</td>
<td>$5.4</td>
<td>$5.4</td>
<td>$30.00</td>
<td>$48.6K</td>
<td>818</td>
<td align="right">0</td>
</tr>
<tr>
<td>SYM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$15.5</td>
<td>$15.3</td>
<td>$15.5</td>
<td>$22.50</td>
<td>$41.8K</td>
<td>258</td>
<td align="right">27</td>
</tr>
<tr>
<td>SYM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$2.15</td>
<td>$1.9</td>
<td>$2.07</td>
<td>$30.00</td>
<td>$41.3K</td>
<td>2.9K</td>
<td align="right">571</td>
</tr>
<tr>
<td>SYM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/24/25</td>
<td>$2.65</td>
<td>$2.2</td>
<td>$2.2</td>
<td>$30.00</td>
<td>$38.5K</td>
<td>1.1K</td>
<td align="right">289</td>
</tr>
</tbody>
</table>

<h3>About Symbotic</h3>
Symbotic Inc is an automation technology company that develops technologies to improve operating efficiencies in modern warehouses. The group develops, commercializes, and deploys end-to-end technology solutions that dramatically improve supply chain operations. Th company also automates the processing of pallets and cases in large warehouses or distribution centers for some of the retail and wholesale companies in the world. The company operates in two geographical regions the United States and Canada. Key revenue is generated from the United States.
Having examined the options trading patterns of Symbotic, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Symbotic</h3>
<ul>
<li>Currently trading with a volume of 10,438,753, the SYM's price is up by 20.58%, now at $32.28. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 18 days.</li>
</ul>
<h3>Expert Opinions on Symbotic</h3>
4 market experts have recently issued ratings for this stock, with a consensus target price of $34.75.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from DA Davidson upgraded its action to Buy with a price target of $35. 
&#x2A; An analyst from UBS persists with their Neutral rating on Symbotic, maintaining a target price of $32. 
&#x2A; In a cautious move, an analyst from Citigroup downgraded its rating to Buy, setting a price target of $37. 
&#x2A; In a cautious move, an analyst from Oppenheimer downgraded its rating to Outperform, setting a price target of $35. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Symbotic, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Unpacking the Latest Options Trading Trends in Symbotic

Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) shares are trading higher Thursday after the prominent short-selling firm Hindenburg Research <a href="https://www.benzinga.com/markets/equities/25/01/43022221/smci-stock-gains-over-3-in-thursday-pre-market-after-short-seller-who-alleged-accounting-manipulation-shuts-shop-nikola-block-and-carvana-also-in-focus">announced its closure</a>.
What To Know: Hindenburg, known for high-profile short reports, accused Super Micro Computer last year of accounting manipulation, sibling self-dealing, and sanctions evasion, triggering significant scrutiny of the company.
The firm, founded in 2017 by Nathan Anderson, gained attention for investigations targeting major companies, including Nikola Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKLA#NASDAQ">NKLA</a>), India's Adani Group, and Jack Dorsey's Block Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQ#NYSE">SQ</a>). Hindenburg's reports often caused steep stock price drops and legal challenges for its targets. For instance, its 2023 exposé on Adani Group led to a $100 billion market value loss, while its 2020 report on Nikola resulted in the resignation of its founder Trevor Milton.
Hindenburg&#8217;s closure, attributed to personal reasons, potentially marks the end of an influential era in short selling. The firm&#8217;s final report accused Carvana Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) of accounting irregularities, allegations the company denied. 
Anderson plans to document Hindenburg's investigative methods over the next six months, aiming to inspire future market watchdogs and analysts.
SMCI Price Action: Super Micro Computer shares were up 2.3% at $31.68 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011625&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="540" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16132652/Screenshot-2025-01-16-at-13.22.41-1024x540.png" alt="" class="wp-image-737465" style="width:440px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16132652/Screenshot-2025-01-16-at-13.22.41-1024x540.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16132652/Screenshot-2025-01-16-at-13.22.41-300x158.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16132652/Screenshot-2025-01-16-at-13.22.41-768x405.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16132652/Screenshot-2025-01-16-at-13.22.41.png 1530w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/travel/25/01/43036258/polar-vortex-brings-winters-coldest-air-for-trumps-inauguration-day-what-it-means-for-utilities-retailers-energy-stocks">Polar Vortex Brings Winter&#8217;s Coldest Air For Trump&#8217;s Inauguration Day: What It Means For Utilities, Retailers, Energy Stocks</a></li>
</ul>
Image Via Shutterstock.

CVNA

NKLA

SMCI

Super Micro Computer Shares Are On The Rise: What's Going On?

Keefe, Bruyette &amp; Woods analyst Aidan Hall raised the price forecast on BlackRock, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) to $1,180 from $1,160 <a target="_blank" href="https://www.benzinga.com/quote/blk/analyst-ratings" rel="noreferrer noopener">while maintaining an Outperform rating</a>.
On Wednesday, the investment giant&nbsp;reported fourth-quarter results, with revenue of&nbsp;$5.68 billion, beating the consensus of&nbsp;$5.53 billion and adjusted EPS of $11.93,&nbsp;<a target="_blank" href="https://www.benzinga.com//node/42997625" rel="noreferrer noopener">surpassing the consensus of&nbsp;$11.21</a>.
The analyst writes that BLK shares responded favorably to the results, surpassing both peers and the broader market by more than 300 basis points.
BlackRock is still in the early phases of its transformation, with management&#8217;s commentary remaining constructive on growth initiatives for 2025, adds the analyst.
Notably, Hall writes that management highlighted ongoing initiatives to meet the growing demand for alternative investments in the retail channel.
These include a managed model partnership with Partners Group, offering a single-subscription document with three risk profiles and a mix of BlackRock and Partners Group funds, adds the analyst.
Also, the analyst writes that management expects core G&amp;A growth in the mid-to-high single digits for 2025, including expenses related to GIP and Preqin.
Hall now anticipates $152.5 million in G&amp;A expenses from GIP and Preqin and expects core G&amp;A to grow 7.9% in 2025, excluding HPS, which the analyst model to close by June 30.
Management also expects continued operating margin expansion, driven by a more variable expense base, with the analyst projecting an estimated 80bps margin improvement to 45.3% in 2025.
Consequently, the analyst slightly adjusted EPS estimates to $10.94 (from $10.92) for first-quarter FY25, $47.23 (from $46.94) for 2025 and $53.62 (from $53.89) for 2026.
The revisions reflect higher operating expenses, primarily from compensation and benefits, as well as amortization of intangibles, partially offset by higher total revenue, says the analyst.
Investors can gain exposure to the stock via&nbsp;Fidelity Disruptive Finance ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FDFF#NASDAQ">FDFF</a>) and Spinnaker ETF Series Genter Capital International Dividend ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GENW#NYSE">GENW</a>).
Price Action: BLK shares are down 2.44% at $988.42 at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/43027627" target="_blank" rel="noreferrer noopener">BlackRock&#8217;s ETF Business Excels In 2024 With Record $390 Billion Net Inflows</a></li>
</ul>
Photo by rafapress on Shutterstock.

Analyst Color

Large Cap

Price Target

Reiteration

Analyst Ratings

FDFF

GENW

BlackRock Warrants Premium Valuation, Analyst Highlights Growth Potential And Initiatives

Citigroup Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) reported a <a href="https://www.benzinga.com/news/buybacks/25/01/43002760/citigroup-q4-earnings-12-topline-growth-2-9-billion-net-income-20-billion-share-buyback-gains-in-wealth-and-market-segments" target="_blank" rel="noreferrer noopener">fourth-quarter fiscal 2024</a> revenue growth of 12% to $19.58 billion, topping the analyst consensus estimate of $19.48 billion. 
Earnings per share, or EPS, of $1.34 beat the analyst consensus estimate of $1.22.
The board also approved a new, multi-year $20 billion share buyback program. Now the bank expects a fiscal 2025 revenue of $83.5 billion to $84.5 billion, above the consensus estimate of $83.2 billion. Here&#8217;s how analysts reacted:
<ul>
<li>Goldman Sachs analyst Richard Ramsden maintained Citigroup with a Buy and raised the <a target="_blank" href="https://www.benzinga.com/quote/C/analyst-ratings" rel="noreferrer noopener">price target from&nbsp;$77&nbsp;to&nbsp;$86</a>.</li>
<li>Keefe, Bruyette &amp; Woods analyst David Konrad reiterated Citigroup with an Outperform and raised the price target from&nbsp;$85&nbsp;to&nbsp;$92.</li>
<li>Truist analyst John McDonald assigned a Buy rating to Citigroup.</li>
</ul>
Also Read: <a href="https://www.benzinga.com/news/earnings/25/01/43026092/bank-of-america-q4-earnings-6-7-billion-profit-1-7-billion-in-investment-banking-fees-forecasts-higher-nii-in-2025" target="_blank" rel="noreferrer noopener">Bank of America Q4 Earnings: $6.7 Billion Profit, $1.7 Billion In Investment Banking Fees</a>
Goldman Sachs: Citi managed to deliver about 3.5% revenue growth, decline in expense, and increasing buyback in 2024. The stock reaction reflects management&#8217;s outlook reassuring continued improvement in ROTCE in the coming years, supported by the buyback, decline in expense from the current run rate and positive operating leverage through 2026, and unchanged revenue growth profile even with the expense initiatives, which Ramsden estimates to grow roughly 4% in 2025 and 2026.
While management cut its ROTCE target by 100bps to 10%-11%, Ramsden noted that the market was not expecting Citi to reach the high end of its target by 2026. Management reiterated that return improvements will continue into 2027 and beyond. Ramsden now expects Citi to generate ROTCEs of 8.7% in 2025 and 10.5% in 2026.
Keefe, Bruyette &amp; Woods: It was a solid quarter for Citi with a revenue beat driven by net interest income (NII), which included more significant than expected trading NII results. The stock was strong following the results, outperforming the KBW Nasdaq Bank Index (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKX#NASDAQ">BKX</a>) by 240bps, as the 2025 guidance was better than feared. Management did lower its 2026 ROTCE outlook from 11% to a range of 10% to 11% owing to higher franchise investments; however, the consensus was below the low point of this range, and it may provide a more visible glide path.
Although Citi&#8217;s stock has been historically cheap, Konrad noted that near-term catalysts make the stock more attractive. First, Citi is well positioned with its franchise, and recent management changes position the firm to capture revenue opportunities in investment banking and trading, given expectations for improved market conditions following the election, particularly in M&amp;A, ECM, and FICC trading. Second, decreasing regulations could ease some control and procedure risks for Citi and provide meaningful capital relief.
Importantly, Konrad expects buybacks to accelerate, with a potential further acceleration should Basel III Endgame be meaningfully watered down. Given Citi&#8217;s Below-Tangible Book Value (TBV)&nbsp;valuation, this could be a strong catalyst for Citi.
The price target represents 9.8 times Konrad&#8217;s 2026E EPS. The analyst noted his price target is sensitive to changes in the macro environment, including interest rates, credit quality, and company-specific operations.
Truist: Citi lowers its 2026 ROTCE target to 10%-11% and guides 2025 revenues +3%-4% YoY to $83.5 billion-84.5 billion, ahead of consensus at $83.3 billion. Expenses for 2025 are guided down to &#8220;slightly lower than ~$53.8 billion&#8221; versus consensus at $53.4 billion. 
Citi also announced a new $20 billion share repurchase authorization, and its $2.1 billion buyback in the fourth quarter of 2024 was ahead of consensus expectations. The fourth-quarter EPS of $1.34 was beat on the quarter versus the $1.23 consensus. 
The price target is based on 9.1 times McDonald&#8217;s 2026E EPS estimate of $9.30, which assumes a below-peer multiple and reflects Citi&#8217;s inconsistent past execution on prior transformation initiatives and the need to build credibility with the Street.
Price Action: Citigroup stock is down 0.17% at $78.15 at the last check on Thursday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/01/42983278/google-stock-boosted-by-ai-growth-cloud-expansion-and-cost-discipline-despite-doj-and-generative-ai-challenges-analyst" target="_blank" rel="noreferrer noopener">Google Stock Boosted By AI Growth, Cloud Expansion, Cost Discipline Despite DOJ And Generative AI Challenges: Analyst</a></li>
</ul>
Image: Shutterstock

Citi Outperforms Analyst Expectations With 12% Revenue Growth, Confirms $20 Billion Buyback Plan

LUXH

LuxUrban Says Transition To OTC Will Reduce Costs, Fuel Hotel Asset Expansion; Achieved Cash Flow Positivity Dec 2024, Aims For Profitability 2025; Enhances Guest Experience, Strategic Asset Acquisitions To Boost Market Presence

Citigroup analyst Paul Diamond maintains Expand Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXE#NASDAQ">EXE</a>) with a Buy and raises the price target from $115 to $125.

Citigroup Maintains Buy on Expand Energy, Raises Price Target to $125

In a court filing on Monday, the Department of Health and Human Services (HHS) challenged Vertex Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>), defending its stance that the company&#8217;s proposed fertility services program would breach anti-kickback laws. The program is tied to Vertex&#8217;s gene-editing therapy Casgevy for sickle cell disease and transfusion-dependent beta-thalassemia.
Vertex&nbsp;<a href="https://assets.bwbx.io/documents/users/iqjWHBFdfxIU/rnMCje2Jspgw/v0" target="_blank" rel="noreferrer noopener">sued</a>&nbsp;the HHS in July 2024.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/12/42324351/fda-approved-sickle-cell-therapies-from-bluebird-bio-and-vertex-join-medicaid-innovation-program" rel="noreferrer noopener">FDA-Approved Sickle Cell Therapies From Bluebird Bio And Vertex Join Medicaid Innovation Program</a>
The gene-editing treatment requires high-dose chemotherapy to clear stem cells from the bone marrow, often causing severe side effects, including infertility. To support patients, Vertex provides financial assistance for fertility preservation options like freezing eggs, embryos or reproductive tissues.
Last year, the HHS Office of Inspector General (OIG) confirmed its decision that it could not issue a favorable advisory opinion. According to OIG, the program implicates the anti-kickback statute, poses more than a low risk of fraud and abuse, and does not promote access to gene therapy care.
Also Read: <a href="https://www.benzinga.com/25/01/42987342/vertex-pharmaceuticals-sets-sights-on-expanding-portfolio-with-alyftrek-approval-pain-treatment-progress-and-diabetes-trials" target="_blank" rel="noreferrer noopener">Vertex Pharmaceuticals Sets Sight on Expanding Portfolio with Alyftrek Approval, Pain Treatment Progress, and Diabetes Trials</a>
The biotech challenged this allegation, "the Fertility Preservation Program would not improperly skew medical decision-making or provide an improper inducement to prescribe," nor would it persuade patients to "undergo treatment with Casgevy in exchange for the Fertility Preservation Program."
Endpoints <a target="_blank" href="https://endpts.com/wp-content/uploads/2025/01/show_temp.pdf" rel="noreferrer noopener">published</a> a copy of the lawsuit online Wednesday.
HHS laid out several arguments, claiming Vertex's attempts to &#8220;twist the statute's meaning&#8221; and that the biotech is "grasping at straws&#8230;"
"The point is that Vertex's offer of fertility treatment in exchange for purchasing its product, and only its product, is meant to induce patients to choose that product when they otherwise might not. That is a quintessential quid pro quo," the HHS said.
"Vertex is not offering $70,000 to any sickle cell patient who undergoes myeloablative conditioning to prepare for treatment, regardless whether that patient elects to purchase Vertex's product, or its competitor's similar gene-therapy product, or a bone- and blood-marrow transplant," the HHS wrote. "Vertex is only offering payments on behalf of patients who select its own product."
&#8220;Vertex then posits that its $70,000 offer will not interfere with or skew clinical decisionmaking because fertility services "benefit a patient's quality of life," HHS noted.
&#8220;This is nonsensical. Many offers of remuneration would enhance patient quality of life, but that doesn't render them lawful," the HHS added.
VRTX Price Action: Vertex stock is down 1.41% at $418.29 at publication Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43036259/canadian-national-railways-valuation-is-an-opportunity-analyst-shifts-to-bullish-outlook" target="_blank" rel="noreferrer noopener">Canadian National Railway&#8217;s Valuation Is An Opportunity, Analyst Shifts To Bullish Outlook</a></li>
</ul>
Photo: Courtesy Vertex Pharmaceuticals

Government

Legal

VRTX

HHS Challenges Vertex Over Fertility Services Program Tied To Casgevy Gene Therapy, Says Company Is 'Grasping at Straws'

Citigroup analyst Alicia Yap maintains iQIYI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IQ#NASDAQ">IQ</a>) with a Buy and lowers the price target from $3 to $2.8.

Citigroup Maintains Buy on iQIYI, Lowers Price Target to $2.8

ORCL

SNAP

Billionaire Frank McCourt Says He Is Open To TikTok's Founder And Original Investors Remaining Involved Following Any Deal To Acquire The Co's U.S. Operation

Citigroup analyst Steven Enders maintains Workday (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>) with a Neutral and lowers the price target from $287 to $270.

WDAY

Citigroup Maintains Neutral on Workday, Lowers Price Target to $270

<a href="https://www.sportsbookreview.com/news/light-wonder-partner-penn-entertainment-new-product-jan-16-2024/">https://www.sportsbookreview.com/news/light-wonder-partner-penn-entertainment-new-product-jan-16-2024/</a>
It may not be the parent company of one of our&nbsp;<a href="https://www.sportsbookreview.com/betting-sites/">best sports betting sites</a>, but PENN Entertainment is certainly doing its best to make moves to continue to make a name for itself and promote growth.
The iGaming group Light &amp; Wonder has announced that it is launching its new player engagement product portfolio on PENN Entertainment's online Hollywood Casino platform in the&nbsp;<a href="https://www.sportsbookreview.com/casino/us/michigan/">Michigan online casino</a>&nbsp;market.

PENN

Light & Wonder Partner With PENN Entertainment To Launch New Product, A New Player Engagement Product Portfolio On PENN Entertainment's Online Hollywood Casino Platform In The Michigan Online Casino Market

Citigroup analyst Steven Enders maintains Paycor HCM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYCR#NASDAQ">PYCR</a>) with a Neutral and raises the price target from $21 to $22.5.

PYCR

Citigroup Maintains Neutral on Paycor HCM, Raises Price Target to $22.5

Metals Corp (MTAL) has released an update. Metals Acquisition Limited has launched an institutional placement to raise approximately A$140 million ...

Metals Corp Announces Major Fundraising Placement

Metals Corp (MTAL) has released an update. Metals Acquisition Limited has successfully completed a significant funding round, securing approximatel...

Metals Corp Secures Major Funding for Growth

Metals Acquisition raises ~A$150M in private offering

Metals Corp (MTAL) has released an update. Metals Acquisition Limited has announced its upcoming Annual General Meeting scheduled for November 21-2...

Metals Acquisition Schedules Hybrid Annual General Meeting

&nbsp;&nbsp;Metals Acquisition Limited reports Q3 results

Metals Corp (MTAL) has released an update. Metals Acquisition Limited reported a strong September quarter, achieving consistent copper production a...

Metals Corp Strengthens Position with Strong Copper Production

Scotiabank analyst Eric Winmill maintained a Buy rating on Metals Corp (MTAL – Research Report) today and set a price target of $16.00. The company...

Metals Corp (MTAL) Receives a Buy from Scotiabank

Metals Corp (MTAL) has released an update. Metals Acquisition Limited successfully passed all resolutions at its 2024 Annual General Meeting, reaff...

Metals Corp Announces Resolutions and Upcoming Name Change

An announcement from Metals Corp ( ($MTAL) ) is now available. MAC Copper Limited has announced an amendment to its loan agreement with Sprott, all...

MAC Copper Limited Secures Early Repayment Option with Sprott

Scotiabank lowered the firm's price target on Metals Acquisition (MTAL) to $14.50 from $16 and keeps an Outperform rating on the shares. The majori...

Metals Acquisition price target lowered to $14.50 from $16 at Scotiabank

Press Releases

Metals Acquisition Limited Announces Annual General Meeting Date and Proposed Name Change

Metals Acquisition Limited Announces ~A$140 Million (~US$96 Million) Placement

Metals Acquisition Limited Raises ~A$150 Million (~US$103 Million) Through Successful Placement

Metals Acquisition Limited Provides Notice of Release of Third Quarter 2024 Results and Conference Call Details

Metals Acquisition Limited Announces September 2024 Quarterly Report

Metals Acquisition Limited Reports Drill Results Including 19.8m @ 10.9% Cu, 27.3m @ 8.7% Cu, 3.8m @ 17.1% Cu and 23.6m @ 5.2% Cu

Metals Acquisition Limited Announces 2024 Annual General Meeting – Chair and CEO Presentation

Metals Acquisition Limited Announces Results of Annual General Meeting

MAC Copper Limited and Sprott Amend Loan Agreement to Permit Early Repayment

MAC Copper Limited Provides Notice of Release of Fourth Quarter 2024 Results and Conference Call Details

Alpha Metallurgical Resources, Inc. Common Stock

Alpha Metallurgical

Compania De Minas

Coeur Mining

Century Aluminum

Compass Minerals Intl

Critical Metals

DRDGOLD Limited American Depositary Shares

DRDGold

Gatos Silver

Ferroglobe

Warrior Met Coal

Ivanhoe Electric

IperionX Limited - American Depositary Share

IperionX

Kaiser Aluminum Corporation - Common Stock

Kaiser Aluminum

Ramaco Resources, Inc. - Class A Common Stock

Ramaco Resources

Ramaco Resources, Inc. - Class B Common Stock

MAC Copper

Materion

Metallus

McEwen Mining

Nexa Res

Ryerson Holding

Sibanye Stillwater

Companhia Siderurgica Nacional S.A. Common Stock

Companhia Siderurgica

SunCoke Energy

TMC the metals company Inc. - Common Stock

TMC Metals

Worthington Steel

Scotiabank

BMO Capital

Canaccord Genuity

Metals Acquisition

<h3 class="wp-block-heading">2024년 5월 28일 주요 뉴스</h3>
골드 로열티(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GROY#NYSE">GROY</a>): 밴쿠버에 본사를 둔 이 회사는 오리온 마인 파이낸스(Orion Mine Finance)로부터 바레스 실버 프로젝트(<a href="https://www.benzinga.com/wiim/24/05/39035910/gold-royalty-shares-are-trading-lower-after-the-company-announced-that-it-entered-into-a-binding-agr" target="_blank" rel="noopener">Vares Silver Project</a>)의 구리 스트림을 5천만 달러에 구매하기로 합의했다. 지급액에는 현금 4,500만 달러와 500만 달러 상당의 골드 로열티 주식이 포함된다.
<ul>
<li>이 스트림은 바레스(Vares)의 루피스(Rupice) 매장지에서 구리 생산량의 100%를 담당하며 LME 현물 구리 가격의 30%로 지속적인 지불을 제공한다.</li>
<li>첫 번째 정광 생산은 2024년 2월에 시작되었으며, 2024년 4분기에 상업 생산이 예상다.</li>
<li>아드리아틱 메탈스(Adriatic Metals)가 운영하는 바레스(Vares) 프로젝트는 광산 수명이 18년이며 2026년까지 연간 생산량을 100만 톤으로 늘릴 계획이다.</li>
</ul>
BHP(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHP#NYSE">BHP</a>)와 리오 틴토(Rio Tinto)는 캐터필러(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>)와 코마츠(Komatsu)의 협력하여 서부 호주의 필바라(Pilbara)에서 배터리 전기 트럭을 테스트할 예정이다.
<ul>
<li>2024년에 CAT 793 트럭 2대, 2026년에 코마츠 930 트럭 2대로 시작되는 이 시험은 이들 트럭의 성능과 생산성을 평가하는 것이 목적이다.</li>
<li>이번 협력은 2050년까지 운영상 순배출량 제로를 달성하려는 두 회사의 목표를 지원한다.</li>
<li>결과는 BHP와 리오 틴토 간에 공유되어 향후 배터리 전기 운반 트럭의 대규모 배치를 알릴 것이다.</li>
</ul>
메탈스 에퀴지션(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTAL#NYSE">MTAL</a>)은 폴리메탈 리소스(Polymetals Resources Limited, POL)의 지분 4.31%에 주당 35 호주센트로 250만 호주달러를 투자하고 있으며, 두 번째 투자는 여러 계약과 엔데버(Endeavour) 광산 재개를 위한 자금 조달을 조건으로 250만 호주달러를 투자한다. 이 호주 광산 및 탐사업체는 지분이 7%를 초과하면 이사회 자리를 얻게 된다.
<ul>
<li>이번 투자에는 4.5년 동안 아연광석 및 연간 150ML의 물 공급을 담당하게 된다.</li>
<li>POL은 상당한 인프라를 갖추고 역사적으로 은, 아연, 납을 생산해 온 엔데버 광산을 다시 시작하는 것을 목표로 하고 있다.</li>
<li>이러한 전략적 움직임은 MAC의 CSA 구리 광산 운영 가치를 높이는 것을 목표로 한다.</li>
</ul>
5E 어드밴스드 머티리얼스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEAM#NASDAQ">FEAM</a>)은 600만 달러의 선순위 전환사채를 발행하고 있다.
<ul>
<li>블루스케이프 에너지 파트너스(Bluescape Energy Partners)와 어센드 글로벌 인베스트먼트 펀드 SPC(Ascend Global Investment Fund SPC)는 각각 2028년 8월 만기 주당 1.53달러에 보통주로 전환 가능한 300만 달러 상당의 채권을 매입할 예정이며 이자는 10% 현물 지급된다.</li>
<li>이 자금은 소규모 시설, FEL-2 엔지니어링 및 상업 계약을 위한 고객 자격을 지원하는 한편 이 회사는 정부 자금을 모색한다.</li>
</ul>
기업소식: <a href="https://www.benzinga.com/government/24/05/39029408/us-military-invests-15-million-in-canadian-mineral-projects-to-secure-critical-resources">미국 군, 캐나다 광물 프로젝트로 1,500만 달러 투자</a>
Benzinga Mining은 광업 기업과 일반 투자자 간의 연결을 돕는 플랫폼입니다. <a href="mailto:licensing@benzinga.com">licensing@benzinga.com</a>을 통해 Benzinga 커뮤니티와 연결하세요!

2024년 5월 21일 주요 뉴스:
1. U.S. 스틸(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>)의 이사회는 올해 하반기에 <a href="https://www.benzinga.com/news/24/05/38941841/united-states-steel-expects-to-close-deal-with-nippon-steel-in-second-half-of-this-year" target="_blank" rel="noopener">종료될 것으로 예상</a>되는 일본제철(Nippon Steel)과의 전액 현금 거래에 대한 잘못된 정보를 다루었다.
그들은 제3자가 승인한 투자자 가치, 고용 안정, 지역 사회 지원 및 국가 안보를 포함한 이 거래의 이점을 강조했다.
그들은 이 거래를 방해하기 위해 거짓 정보를 퍼뜨렸다는 이유로 경쟁자이자 실패한 입찰자 클리블랜드 클리프스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>)를 비난했다.
이사회는 우수한 가치와 낮은 독점 금지 위험 때문에 클리블랜드 클리프스 대신 일본제철의 제안을 선택했다. 이사회는 이번 거래가 U.S. 스틸의 성장, 경쟁 및 혁신을 보장하며 이해관계자들로부터 폭넓은 지지를 받고 있다고 믿는다.
2. 파라마운트 골드 네바다(AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PZG#AMEX">PZG</a>)는 자사의 그라시 산(Grassy Mountain) 금광이 오리건주 지질학 및 광물 산업부(DOGAMI)와 토지 관리국(BLM) 간의 공동 매립 채권의 혜택을 받을 것이라고 발표했다.
이번 협약은 양해각서(MOU)를 통해 체결됐으며 매립채권 1개만 요구해 자본 요건과 행정 부담을 줄였다.
파라마운트의 글렌 반 트리크(Glen Van Treek) 사장은 DOGAMI와 BLM 간의 협력을 칭찬하며 광산 개발 및 운영에 대한 이점을 언급했다.
이 양해각서는 연방 및 사유지 모두에서 광산 운영에 대한 조정된 지침과 모니터링을 보장한다.
이해각을 통해 연방 및 민간 토지에서의 채굴 작업에 대한 조정된 지침 및 모니터링이 보장된다.
기사 읽기: <a href="https://www.benzinga.com/news/large-cap/24/05/38941940/nickel-crisis-fuels-unrest-in-new-caledonia-pushes-prices-above-20-000-per-ton">니켈 위기, 뉴칼레도니아의 불안, 톤당 20,000달러 넘어</a>
3. 메탈스 에퀴지션(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTAL#NYSE">MTAL</a>)은 보통주 매입을 위한 공개 및 사모 발행 채권에 대한 &#8216;환매 공정 시장 가치&#8217;를 발표했다.
이 회사는 2024년 6월 5일에 모든 미결 채권을 각각 10센트에 상환할 예정이다.
채권 보유자는 해당 날짜까지 현금 또는 현금 없이 채권을 행사할 수 있다.
&#8220;상환 공정 시장 가치&#8221;는 13.33달러이며, 무현금 행사에 대해 영장당 보통주 0.3063주를 부여한다. 등록된 영장 보유자에게 통지문이 발송되었다.
4. 알코아(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>)는 알루미나 리미티드(Alumina Limited)와의 인수 계약을 수정하여 주주들이 알루미나 리미티드 주당 0.02854개의 새로운 CHESS 예탁 지분증서(CDI)를 받을 수 있도록 보장했으며 이는 호주 증권 거래소(ASX)에서 거래 가능하다.
미국 규정을 준수하기 위해 CITIC 그룹은 CDI 대신 의결권 없는 우선주로 대가의 약 1.5%를 받게된다.
이 거래는 2024년 3분기에 마무리될 것으로 예상된다.
이제 읽어보세요: <a href="https://www.benzinga.com/24/05/38895301/solitario-resources-finds-new-gold-zones-in-south-dakota-highest-grade-samples-collected">솔리타리오 리소시스, 사우스다코타 주에서 새로운 금 지대 발견, ‘최고급 샘플 수집&#8217;</a>
Benzinga Mining은 채굴 기업과 개인 투자자 간의 연결다리입니다. <a href="mailto:licensing@benzinga.com">licensing@benzinga.com</a>으로 연락하여 Benzinga 커뮤니티와 소통하세요!
사진: 언스플래쉬

1. 알파 메탈러지컬(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMR#NYSE">AMR</a>)은 2024년 1분기 순이익은 1억 2,700만 달러, 즉 희석 주당 9.59달러, 조정 EBITDA는 1억 8,960만 달러, 매출은 8억 6,400만 달러를 기록했다.
최고경영자(CEO) 앤디 아이드슨(Andy Eidson)은 석탄 시장의 약세 조건에도 불구하고 강력한 실적을 이끌어냈다고 언급했으며, 이에 따라 이번 분기 이후로도 시장 악화 조짐이 계속되고 있다고 덧붙였다.
세그먼트 석탄 판매 비용은 2023년 4분기 톤당 119달러에서 2024년 1분기 톤당 115.65달러로 감소했으며, 운영 현금 흐름은 1억 9,610만 달러로 감소하고 자본 지출은 6,360만 달러로 증가했다.
알파의 주식 환매 프로그램은 최대 15억 달러를 승인했으며 2024년 4월 30일까지 회사는 660만 주를 11억 달러에 환매하여 13,007,215주가 발행주로 남았다.
알파의 주식 재매수 프로그램은 최대 15억 달러를 인가 받았으며, 2024년 4월 30일까지 회사는 1.1억 달러에 660만 주의 주식을 재매수하여 이어지는 1307215 주의 주식을 다시 재매수하였다.
2. 메탈스 에퀴지션(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTAL#NYSE">MTAL</a>)은 2024년 6월 5일 보통주에 대한 모든 발행된 공모 및 사모 워런트를 워런트당 10센트에 상환할 것이라고 발표했다.
이는 회사의 단순화된 자본 구조의 목표와 일치한다.
워런트 보유자들은 워런트 1개당 11.50달러에 행사하거나, 현금 없이 보통주 일부에 양도하거나, 회사가 워런트당 10센트에 상환할 수 있다.
또한 읽기: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38621219/glencore-anglo-american-tie-up-makes-more-sense-than-bhp-offer-analyst-says">글렌코어-앵글로 아메리칸 제휴가 BHP와의 제휴보다 합리적</a>
3. 라틴 메탈스(OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMSQF#OTC">LMSQF</a>)은 100% 소유한 오르가눌로(Organullo) 프로젝트에 대한 최신 업데이트를 발표했다. 이 프로젝트는 옵션 협정 덕분에 앵글로골드 아르헨티나 익스플로라시오네스(AngloGold Argentina Exploraciones) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AU#NYSE">AU</a>)는 최대 80%까지 지분을 확보할 수 있다.
앵글로골드의 지구물리학적 조사에서는 웨스트 그라벤(West Graben)에서 우선순위가 높은 드릴 통로가 확인되었다.
사전 매핑 및 샘플링을 통해 6km에 걸쳐 고급 아르길릭 변형이 적용된 3개의 드릴 타겟이 식별되었다.
역사적인 쥘 베른(Julio Verne) 광산 근처에 있는 오르가눌로(Organullo)의 동쪽 그라벤은 과거 탐사를 보았지만 서쪽 그라벤은 간과되었다.
앵글로골드의 전체적인 접근 방식은 시추를 통해 테스트되지 않은 반암 구리-금 및 고황화 천열 금 매장지의 잠재력을 보여줬다.
그들의 탐구 논문은 중요한 발견으로 이어질 수 있다.
4. 2024년 1분기 아이다호 스트래티직 리소시스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IDR#NYSE">IDR</a>)은 매출 76.5% 증가, 주당 17센트의 분기 이익, 순이익 35배 증가를 보여줬다.
금 생산량은 80.6% 증가한 3,116온스였으며 온스당 총 유지 비용은 28.8% 감소한 1,097.09달러였다.
의견을 요청받았을 때 대변인 트래비스 스왈로(Travis Swallow)는 회사가 이제 생산과 탐사에 재투자할 수 있으며 머레이 골드 벨트 지구(Murray Gold Belt District)의 잠재력을 발휘하고 아이다호의 희토류 프로젝트를 발전시키려는 동기를 부여받았다고 말했다.
또한 이 회사는 연간 최대 800,000달러를 절약하는 것을 목표로 계획된 페이스트 백필 시스템을 위해 뷰트 굴치(Butte Gulch) 대지와 리드 타임이 긴 구성 요소를 구입했다.
또한 H&amp;H 메탈스(Metals)와의 갱신된 계약은 매년 최대 400,000 달러까지 절감할 것으로 예상된다.
사진: 셔터스톡

<h4 class="wp-block-heading">2024년 4월 23일 주요 소식:</h4>
<ol>
<li>클리블랜드 클리프스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>)는 매출 52억 달러, 순 손실 5,300만 달러, 조정 순이익 8,700만 달러 등을 포함한 <a href="https://www.benzinga.com/wiim/24/04/38378385/cleveland-cliffs-shares-are-trading-lower-after-the-companys-reported-worse-than-expected-q1-financi">올해 1분기 실적</a>을 보고했다.</li>
</ol>
조정 EBITDA는 4억 1400만 달러로, 이는 전년도와 분기별 개선을 나타내는 중요한 지표이다.
이 회사는 이전에 10억 달러 규모의 자사주 매입 프로그램을 완료하고 3,040만 주를 매입했다고 발표했다. 또한 15억 달러 규모의 새로운 자사주 매입 계획도 도입했다.
철강 출하량은 총 390만 순톤에 달했고 회사는 2024년 3월 말 기준 40억 달러에 달하는 유동성 포지션을 강화하기 위해 나머지 모든 담보 채권을 소각했다.
<ol start="2">
<li>프리포트 맥모란(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>)는 2024년 1월과 2023년 1분기의 추정치를 능가하는 구리 매출과 단위 순현금 비용으로 <a href="https://www.benzinga.com/stock/FCX#NYSE">강력한</a> 2024년 1분기 실적을 발표했다.</li>
</ol>
구리 11억 파운드, 금 568,000온스, 몰리브덴 2,000만 파운드의 통합 매출을 포함해 순이익은 4억 7,300만 달러에 이르렀다.
이 회사의 인도네시아 제련소 프로젝트는 거의 완료되었으며 2024년 2분기에 시작될 것으로 예상된다.
해당 분기 동안 이 회사의 운영 현금 흐름은 총 19억 달러였으며 자본 지출은 13억 달러였다.
캐슬린 L. 쿼크(Kathleen L. Quirk)는 2024년 6월 11일부터 리처드 애드커슨(Richard C. Adkerson)의 후임으로 회사 CEO로 취임할 예정이다.
기사 읽기: <a href="https://www.benzinga.com/news/large-cap/24/04/38364875/geopolitical-relief-triggers-gold-selloff-prices-dip-below-2-350-mark-mining-stocks-hit-hard">지정학적 안정화의 영향으로 금 가격 하락, 2350달러를 밑돌아</a>
<ol start="3">
<li>워딩턴 스틸(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WS#NYSE">WS</a>)는 제너럴 모터스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>)로부터 2020년과 2021년에 이어 3년째로 올해의 &#8216;공급업체(Supplier of the Year)&#8217;로 선정됐다.</li>
</ol>
GM은 안전, 포용성, 관계라는 세 가지 핵심 가치를 강조하며 2023년 성과를 통해 86개 공급업체를 인정했다. 이 것은 혁신과 고품질 자동차 생산이라는 GM의 목표에 기여한 공급업체에게 수여된다.
워딩턴 스틸은 인디애나, 미시간, 오하이오 및 멕시코의 시설 전반에 걸쳐 GM의 차량 생산에 사용되는 평면 롤 탄소강 코일을 제공한다.
<ol start="4">
<li>메탈스 에퀴지션(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTAL#NYSE">MTAL</a>)은 자원 및 광산 수명의 상당한 성장을 강조하는 CSA 구리 광산에 대한 자원 및 매장량 명세서와 3년 생산 지침을 발표했다.</li>
</ol>
주요 업데이트에는 광산 수명이 2034년까지 11년 연장되어 작년보다 67% 증가하고 함유된 구리 함량이 50만 톤으로 64% 증가한 것이 포함된다.
측정 및 표시된 광물 자원은 구리 229,000톤으로 증가했으며, 추가로 184,000톤이 추정으로 분류되었다.
이러한 개선은 인수 후 불과 10개월 만에 이루어졌으며, 자원 확장을 목표로 지속적인 시추 작업이 이루어졌다.
Benzinga Mining은 광산 회사와 일반 투자자 사이의 다리 역할을 하고 있습니다. Benzinga 커뮤니티와 연결하려면 <a href="mailto:licensing@benzinga.com">licensing@benzinga.com</a>으로 연락해 주세요.
사진: 셔터스톡

Comments

MAC Copper

뉴스

에 대한 최신 뉴스 MAC Copper (NYSE:MTAL) 주식

화요일, 5월 28, 2024

화요일, 5월 21, 2024

화요일, 5월 07, 2024

수요일, 4월 24, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌